Evidence map›Paper›PMID 36048758›Full record

ArticlePloS one2022

Time series cross-correlation between home range and number of infected people during the COVID-19 pandemic in a suburban city.

Haruka Kato, Atsushi Takizawa

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Haruka KatoDepartment of Housing and Environmental Design, Graduate School of Human Life and Ecology, Osaka Metropolitan University, Osaka, Japan.ORCID 0000-0003-0831-1543
Atsushi TakizawaDepartment of Housing and Environmental Design, Graduate School of Human Life and Ecology, Osaka Metropolitan University, Osaka, Japan.ORCID 0000-0001-6474-6985

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Control of human mobility is one of the most effective measures to prevent the spread of coronavirus disease 2019 (COVID-19). However, the imposition of emergency restrictions had significant negative impacts on citizens' daily lives. As vaccination progresses, we need to consider more effective measures to control the spread of the infection. The research question of this study is as follows: Does the control of home range correlate with a reduction in the number of infected people during the COVID-19 pandemic? This study aims to clarify the correlation between home range and the number of people infected with SARS-CoV-2 during the COVID-19 pandemic in Ibaraki City. Home ranges are analyzed by the Minimum Convex Polygon method using mobile phone GPS location history data. We analyzed the time series cross-correlation between home range lengths and the number of infected people. Results reveal a slight positive correlation between home range and the number of infected people after one week during the COVID-19 pandemic. Regarding home range length, the cross-correlation coefficient is 0.4030 even at a lag level of six weeks, which has the most significant coefficient. Thus, a decrease in the home range is a weak factor correlated with a reduction in the number of infected people. This study makes a significant contribution to the literature by evaluating key public health challenges from the perspective of controliing the spread of the COVID-19 infectuion. Its findings has implications for policy makers, practitioners, and urban scientists seeking to promote urban sustainability.

Indexed as

COVID-19PandemicsAnimalsCitiesHoming BehaviorHumansSARS-CoV-2Sustainable GrowthTime Factors

Identifiers

PMID36048758
PMCPMC9436136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.